US20050119470A1
(en)
*
|
1996-06-06 |
2005-06-02 |
Muthiah Manoharan |
Conjugated oligomeric compounds and their use in gene modulation
|
US7812149B2
(en)
*
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
US20040147022A1
(en)
*
|
1996-06-06 |
2004-07-29 |
Baker Brenda F. |
2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
|
US20040171031A1
(en)
*
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
US5898031A
(en)
*
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
WO2005121368A1
(en)
*
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Chimeric gapped oligomeric compositions
|
US7572582B2
(en)
|
1997-09-12 |
2009-08-11 |
Exiqon A/S |
Oligonucleotide analogues
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US6583168B1
(en)
|
1997-11-25 |
2003-06-24 |
Applera Corporation |
Sulfonated diarylrhodamine dyes
|
ATE501269T1
(de)
|
1999-03-18 |
2011-03-15 |
Exiqon As |
Detektion von genmutationen mittels lna primer
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
EP1161561B1
(de)
|
1999-03-18 |
2005-12-28 |
Exiqon A/S |
Einstufige probezubereitung und bestimmung von nukleinsäure in biologischen proben
|
WO2000056749A1
(en)
|
1999-03-24 |
2000-09-28 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
N-acylphosphoramidites and their use in oligonucleotide synthesis
|
ATE332909T1
(de)
*
|
1999-03-24 |
2006-08-15 |
Exiqon As |
Verbesserte synthese für 2.2.1.öbicyclo- nukleoside
|
US6734291B2
(en)
*
|
1999-03-24 |
2004-05-11 |
Exiqon A/S |
Synthesis of [2.2.1]bicyclo nucleosides
|
ATE356824T1
(de)
|
1999-05-04 |
2007-04-15 |
Santaris Pharma As |
L-ribo-lna analoge
|
WO2000078775A1
(fr)
*
|
1999-06-22 |
2000-12-28 |
Sankyo Company, Limited |
Nouveaux nucleosides pontes en 3'-4' et analogues d'oligonucleotides
|
AU5429000A
(en)
*
|
1999-06-25 |
2001-01-31 |
Sankyo Company Limited |
Novel bicyclonucleoside derivatives
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
EP1414840A4
(de)
*
|
2001-03-27 |
2005-04-13 |
Univ Delaware |
Genomics-anwendungen für modifizierte oligonukleotide
|
US20040096880A1
(en)
*
|
2001-08-07 |
2004-05-20 |
Kmiec Eric B. |
Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
|
EP1448766A2
(de)
*
|
2001-09-27 |
2004-08-25 |
University Of Delaware |
Coisogene eukaryontische zellansammlungen
|
US7468244B2
(en)
*
|
2001-09-27 |
2008-12-23 |
University Of Delaware |
Polymorphism detection and separation
|
EP1442137A4
(de)
*
|
2001-11-07 |
2005-08-31 |
Applera Corp |
Universelle nukleotide für die nukleinsäureanalyse
|
CA2466821A1
(en)
|
2001-11-21 |
2003-06-05 |
Applera Corporation |
Digital assay
|
US7355037B2
(en)
*
|
2001-12-03 |
2008-04-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thermolabile hydroxyl protecting groups and methods of use
|
JP2005518817A
(ja)
*
|
2002-03-07 |
2005-06-30 |
ユニバーシティー、オブ、デラウェア |
ヒストン・デアセチラーゼ・インヒビタ、ラムダファージベータ蛋白、またはヒドロキシウレアを含む組成物を使用してオリゴヌクレオチド媒介性核酸配列改変を高める方法、組成物およびキット
|
US20030198960A1
(en)
*
|
2002-04-01 |
2003-10-23 |
Wenhong Fan |
Signal amplifying targeted reporters for biological and chemical sensor applications
|
US7005265B1
(en)
|
2002-06-20 |
2006-02-28 |
Wenhong Fan |
Nonenzymatic catalytic signal amplification for nucleic acid hybridization assays
|
US20040175722A1
(en)
*
|
2002-10-07 |
2004-09-09 |
Kmiec Eric B. |
Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
|
US20040219565A1
(en)
|
2002-10-21 |
2004-11-04 |
Sakari Kauppinen |
Oligonucleotides useful for detecting and analyzing nucleic acids of interest
|
AU2003291753B2
(en)
*
|
2002-11-05 |
2010-07-08 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
EP1578765A4
(de)
*
|
2002-11-05 |
2008-04-23 |
Isis Pharmaceuticals Inc |
Oligomere verbindungen,die zuckerersatzstoffe enthalten, und zusammensetzung zur verwendung in dergenmodulation
|
AU2004227362B2
(en)
|
2003-04-01 |
2008-06-26 |
Activx Biosciences, Inc. |
Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
|
WO2005002507A2
(en)
|
2003-06-03 |
2005-01-13 |
Isis Pharmaceuticals, Inc. |
Modulation of survivin expression
|
US20050089889A1
(en)
*
|
2003-06-20 |
2005-04-28 |
Ramsing Niels B. |
Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
|
WO2005044976A2
(en)
*
|
2003-06-20 |
2005-05-19 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds for use in gene modulation
|
US20050053981A1
(en)
*
|
2003-09-09 |
2005-03-10 |
Swayze Eric E. |
Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
|
EP2182063A3
(de)
|
2003-09-18 |
2012-07-18 |
Isis Pharmaceuticals, Inc. |
Modulierung von EIF4E-Expression
|
PT1538154E
(pt)
|
2003-11-20 |
2009-03-23 |
Exiqon As |
Composições de agentes de extinção com porções de antraquinona
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
US8192937B2
(en)
*
|
2004-04-07 |
2012-06-05 |
Exiqon A/S |
Methods for quantification of microRNAs and small interfering RNAs
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
AU2005252662B2
(en)
*
|
2004-06-03 |
2011-08-18 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
US7884086B2
(en)
*
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
US9809824B2
(en)
*
|
2004-12-13 |
2017-11-07 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
US20060166238A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Ramsing Niels B |
Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
|
US20070099196A1
(en)
|
2004-12-29 |
2007-05-03 |
Sakari Kauppinen |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs
|
US20060228726A1
(en)
|
2005-01-06 |
2006-10-12 |
Martin Patrick K |
Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification
|
US20060153745A1
(en)
*
|
2005-01-11 |
2006-07-13 |
Applera Corporation |
Fluid processing device for oligonucleotide synthesis and analysis
|
US20070065840A1
(en)
*
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
US20070128620A1
(en)
|
2005-07-15 |
2007-06-07 |
Applera Corporation |
Hot start reverse transcription by primer design
|
ATE489473T1
(de)
|
2005-07-15 |
2010-12-15 |
Life Technologies Corp |
Analyse von boten-rna und mikro-rna im gleichen reaktionsansatz
|
US20070059713A1
(en)
|
2005-09-09 |
2007-03-15 |
Lee Jun E |
SSB-DNA polymerase fusion proteins
|
EP2458011B1
(de)
|
2005-10-03 |
2013-07-24 |
Life Technologies Corporation |
Zusammensetzungen, Verfahren und Kits zur Amplifikation von Nukleinsäuren
|
EP3000480A1
(de)
|
2005-12-01 |
2016-03-30 |
ProNAi Therapeutics, Inc. |
Krebstherapien und dabei verwendete pharmazeutische zusammensetzungen
|
WO2007073149A1
(en)
|
2005-12-22 |
2007-06-28 |
Keygene N.V. |
Alternative nucleotides for improved targeted nucleotide exchange
|
US20100286044A1
(en)
*
|
2005-12-29 |
2010-11-11 |
Exiqon A/S |
Detection of tissue origin of cancer
|
PT2161038E
(pt)
|
2006-01-26 |
2014-03-10 |
Isis Pharmaceuticals Inc |
Composições e suas utilizações dirigidas à huntingtina
|
EP2314594B1
(de)
|
2006-01-27 |
2014-07-23 |
Isis Pharmaceuticals, Inc. |
6-Modifizierte bicyclische Nukleinsäureanaloga
|
US9677123B2
(en)
|
2006-03-15 |
2017-06-13 |
Siemens Healthcare Diagnostics Inc. |
Degenerate nucleobase analogs
|
US20090326041A1
(en)
|
2006-05-05 |
2009-12-31 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of sglt2
|
DK2066684T3
(da)
|
2006-05-11 |
2012-10-22 |
Isis Pharmaceuticals Inc |
5´-Modificerede bicycliske nukleinsyreanaloge
|
US7666854B2
(en)
*
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
US20090023221A1
(en)
*
|
2006-05-19 |
2009-01-22 |
Exigon A/S |
Oligonucleotide probes useful for detection and analysis of microrna precursors
|
WO2007137301A2
(en)
*
|
2006-05-23 |
2007-11-29 |
Isis Pharmaceuticals, Inc. |
Modulation of chrebp expression
|
US20080076674A1
(en)
*
|
2006-07-06 |
2008-03-27 |
Thomas Litman |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer
|
US8198253B2
(en)
|
2006-07-19 |
2012-06-12 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to HBXIP
|
US8012685B2
(en)
|
2006-08-01 |
2011-09-06 |
Applied Biosystems, Llc |
Detection of analytes and nucleic acids
|
EP2090665A2
(de)
|
2006-10-20 |
2009-08-19 |
Exiqon A/S |
Neue humane MikroRNAs im Zusammenhang mit Krebs
|
US8188255B2
(en)
*
|
2006-10-20 |
2012-05-29 |
Exiqon A/S |
Human microRNAs associated with cancer
|
US8093222B2
(en)
|
2006-11-27 |
2012-01-10 |
Isis Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia
|
CA2670563A1
(en)
|
2006-11-27 |
2008-06-05 |
Isis Pharmaceuticals, Inc. |
Methods for treating hypercholesterolemia
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
WO2008074328A2
(en)
*
|
2006-12-21 |
2008-06-26 |
Exiqon A/S |
Microrna target site blocking oligos and uses thereof
|
EP3536788A1
(de)
|
2006-12-21 |
2019-09-11 |
QIAGEN GmbH |
Mikro-rna-zielortblockierende oligos und verwendungen davon
|
US8048998B2
(en)
*
|
2007-01-19 |
2011-11-01 |
Exiqon A/S |
Mediated cellular delivery of LNA oligonucleotides
|
US8999634B2
(en)
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
US20100261175A1
(en)
*
|
2007-06-15 |
2010-10-14 |
Exiqon A/S |
Use of short oligonucleotides for reagent redundancy experiments in rna functional analysis
|
US8017338B2
(en)
|
2007-11-20 |
2011-09-13 |
Life Technologies Corporation |
Reversible di-nucleotide terminator sequencing
|
WO2009076323A2
(en)
|
2007-12-06 |
2009-06-18 |
Genalyte Inc. |
Monitoring enzymatic process
|
CN101903420B
(zh)
|
2007-12-18 |
2012-09-19 |
巴塞尔聚烯烃股份有限公司 |
α-烯烃聚合的气相方法
|
US20100113284A1
(en)
*
|
2008-04-04 |
2010-05-06 |
Alexander Aristarkhov |
Small interfering rna (sirna) target site blocking oligos and uses thereof
|
US20090326049A1
(en)
*
|
2008-04-04 |
2009-12-31 |
Alexander Aristarkhov |
Blocking oligos for inhibition of microrna and sirna activity and uses thereof
|
EP2317847B1
(de)
*
|
2008-07-29 |
2019-04-17 |
The Board of Regents of The University of Texas System |
Selektive hemmung der polyglutamin-proteinexpression
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
WO2010062627A2
(en)
|
2008-10-27 |
2010-06-03 |
Genalyte Inc. |
Biosensors based on optical probing and sensing
|
EP2376637A1
(de)
|
2008-12-22 |
2011-10-19 |
Keygene N.V. |
Verwendung von doppelstrang-rna zur erhöhung der wirksamkeit einer zielgenänderung in pflanzenprotoplasten
|
EP2432796B1
(de)
|
2009-05-21 |
2016-08-17 |
Siemens Healthcare Diagnostics Inc. |
Universaltags mit nicht-natürlichen nukleobasen
|
US20110196141A1
(en)
*
|
2009-09-07 |
2011-08-11 |
Council Of Scientific & Industrial Research |
Locked and unlocked 2'-o phosphoramidite nucleosides, process of preparation thereof and oligomers comprising the nucleosides
|
KR102279458B1
(ko)
|
2009-09-11 |
2021-07-21 |
아이오니스 파마수티컬즈, 인코포레이티드 |
헌팅틴 발현의 조절
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
US8927271B1
(en)
*
|
2010-01-21 |
2015-01-06 |
Jack T. Johansen |
Compositions and methods for detecting target analytes
|
ES2465948T3
(es)
|
2010-04-30 |
2014-06-09 |
Exiqon A/S |
Procedimiento de hibridación in situ y tampón
|
WO2012006551A2
(en)
|
2010-07-08 |
2012-01-12 |
The Brigham And Women's Hospital, Inc. |
Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
|
CA2803011C
(en)
|
2010-07-16 |
2019-12-03 |
Tocagen Inc. |
Retrovirus detection
|
EP3266881B1
(de)
|
2010-11-05 |
2019-12-25 |
Genalyte, Inc. |
Systeme zur optischen analytdetektion und verfahren zur verwendung
|
DK2646549T3
(en)
|
2010-12-02 |
2015-05-26 |
Keygene Nv |
Targeted DNA change
|
EP2646550B1
(de)
|
2010-12-02 |
2015-02-18 |
Keygene N.V. |
Gezielte änderung von dna mit oligonukleotiden
|
MX352460B
(es)
|
2011-01-11 |
2017-11-24 |
Seegene Inc |
Detección de secuencias de ácido nucleico objetivo mediante ensayo de escisión y extensión del pto.
|
EP2691543B1
(de)
|
2011-03-29 |
2017-11-01 |
Seegene, Inc. |
Erkennung von zielnukleinsäuresequenzen durch pto-spaltung und verlängerungsabhängige spaltung
|
AU2012249531B2
(en)
|
2011-04-29 |
2017-06-29 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
WO2012150749A1
(en)
|
2011-05-04 |
2012-11-08 |
Seegene, Inc. |
Detection of target nucleic acid sequences by po cleavage and hybridization
|
US10202599B2
(en)
|
2011-08-11 |
2019-02-12 |
Ionis Pharmaceuticals, Inc. |
Selective antisense compounds and uses thereof
|
EP2820129A1
(de)
|
2012-03-02 |
2015-01-07 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
CA2864523C
(en)
|
2012-03-05 |
2019-02-05 |
Seegene, Inc. |
Detection of nucleotide variation on target nucleic acid sequence by pto cleavage and extension assay
|
EP3907506A1
(de)
|
2012-03-12 |
2021-11-10 |
The Board of Trustees of the University of Illinois |
Optische analytdetektionssysteme mit magnetischer verstärkung und verfahren zu deren verwendung
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2014015098A1
(en)
|
2012-07-18 |
2014-01-23 |
Siemens Healthcare Diagnostics Inc. |
A method of normalizing biological samples
|
US20150299803A1
(en)
|
2012-11-05 |
2015-10-22 |
Pronai Therapeutics, Inc. |
Methods of Using Biomarkers for the Treatment of Cancer by Modulation of BCL2 Expression
|
WO2014093291A1
(en)
|
2012-12-10 |
2014-06-19 |
Advandx, Inc. |
Use of probes for mass spectrometric identification of microorganisms or cells and associated conditions of interest
|
AU2014200958B2
(en)
|
2013-02-25 |
2016-01-14 |
Seegene, Inc. |
Detection of nucleotide variation on target nucleic acid sequence
|
WO2014134144A1
(en)
|
2013-02-28 |
2014-09-04 |
The General Hospital Corporation |
Mirna profiling compositions and methods of use
|
AU2014222150A1
(en)
|
2013-03-01 |
2015-09-10 |
National University Corporation Tokyo Medical And Dental University |
Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
US10106840B2
(en)
|
2013-03-13 |
2018-10-23 |
Seegene, Inc. |
Quantification of target nucleic acid using melting peak analysis
|
EP3495505A1
(de)
|
2013-03-14 |
2019-06-12 |
Translate Bio, Inc. |
Quantitative beurteilung für kappeneffizienz von messenger-mrna
|
BR112015022505A2
(pt)
|
2013-03-14 |
2017-10-24 |
Shire Human Genetic Therapies |
avaliação quantitativa para eficiência do cap de rna mensageiro
|
US9983206B2
(en)
|
2013-03-15 |
2018-05-29 |
The Board Of Trustees Of The University Of Illinois |
Methods and compositions for enhancing immunoassays
|
JP6472087B2
(ja)
|
2013-05-30 |
2019-02-27 |
国立大学法人 東京医科歯科大学 |
治療用オリゴヌクレオチドを送達するための二本鎖剤
|
EP3010514B1
(de)
|
2013-06-16 |
2021-01-20 |
National University Corporation Tokyo Medical and Dental University |
Doppelsträngige antisense-nukleinsäure mit exon-skipping-wirkung
|
EP3022319B1
(de)
|
2013-07-15 |
2023-05-17 |
Seegene, Inc. |
Erkennung einer nukleinsäurezielsequenz durch pto-spaltung und erweiterungsabhängige immobilisierte oligonukleotidhybridisierung
|
US10159652B2
(en)
|
2013-10-16 |
2018-12-25 |
The University Of British Columbia |
Device for formulating particles at small volumes
|
KR101757473B1
(ko)
|
2013-10-18 |
2017-07-13 |
주식회사 씨젠 |
hCTO를 이용하는 PTO 절단 및 연장 분석에 의한 고상에서의 타겟 핵산 서열 검출
|
WO2015075166A1
(en)
|
2013-11-22 |
2015-05-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for treatment of a bacterial infection
|
WO2015118407A2
(en)
|
2014-01-29 |
2015-08-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Oligonucleotides and methods for inhibiting or reducing bacterial biofilms
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
HRP20220379T1
(hr)
|
2014-06-10 |
2022-05-27 |
Erasmus University Medical Center Rotterdam |
Antisense oligonukleotidi korisni u liječenju pompeove bolesti
|
EP3183347A4
(de)
|
2015-10-17 |
2018-04-18 |
Lifesplice Pharma LLC |
Spleissmodulierende oligonukleotide und verfahren zur verwendung davon
|
US10865396B2
(en)
|
2015-10-29 |
2020-12-15 |
Temple University—Of the Commonwealth System of Higher Education |
Modification of 3′ terminal ends of nucleic acids by DNA polymerase theta
|
AU2015416656B2
(en)
|
2015-12-07 |
2023-02-23 |
Erasmus University Medical Center Rotterdam |
Enzymatic replacement therapy and antisense therapy for Pompe disease
|
US20210108252A1
(en)
|
2015-12-09 |
2021-04-15 |
Novartis Ag |
Label-free analysis of rna capping efficiency using rnase h, probes and liquid chromatography/mass spectrometry
|
CA3009691C
(en)
|
2016-01-06 |
2021-12-07 |
The University Of British Columbia |
Bifurcating mixers and methods of their use and manufacture
|
NL2017295B1
(en)
|
2016-08-05 |
2018-02-14 |
Univ Erasmus Med Ct Rotterdam |
Antisense oligomeric compound for Pompe disease
|
NL2017294B1
(en)
|
2016-08-05 |
2018-02-14 |
Univ Erasmus Med Ct Rotterdam |
Natural cryptic exon removal by pairs of antisense oligonucleotides.
|
WO2019045532A2
(en)
|
2017-08-31 |
2019-03-07 |
Seegene, Inc. |
EVALUATION OF COMPONENT PERFORMANCE USING A PAIR OF DIMER FORMER PRIMERS
|
EP3688188A4
(de)
|
2017-09-29 |
2021-06-16 |
Seegene, Inc. |
Detektion von zielnukleinsäuresequenzen durch pto-spaltung und erweiterungsabhängiger nicht-hybridisierungstest
|
US11261445B2
(en)
|
2017-10-17 |
2022-03-01 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Combination treatment for cystic fibrosis
|
US20200325532A1
(en)
|
2017-12-15 |
2020-10-15 |
Novartis Ag |
Polya tail length analysis of rna by mass spectrometry
|
WO2021005223A1
(en)
|
2019-07-10 |
2021-01-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment of epilepsy
|
WO2021074657A1
(en)
|
2019-10-17 |
2021-04-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Combination treatment for cystic fibrosis
|
WO2021099394A1
(en)
|
2019-11-19 |
2021-05-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antisense oligonucleotides and their use for the treatment of cancer
|
AU2021247043A1
(en)
|
2020-03-31 |
2022-10-27 |
Janssen Biopharma, Inc. |
Synthesis of oligonucleotides and related compounds
|
IL299771A
(en)
|
2020-07-10 |
2023-03-01 |
Inst Nat Sante Rech Med |
Methods and compounds for the treatment of epilepsy
|
EP4347875A1
(de)
|
2021-06-04 |
2024-04-10 |
Translate Bio, Inc. |
Test zur quantitativen beurteilung der mrna-kappungseffizienz
|
WO2023043280A1
(ko)
|
2021-09-17 |
2023-03-23 |
주식회사 씨젠 |
합성 비자연 염기를 포함하는 태그 올리고뉴클레오타이드를 이용한 타겟 핵산 서열의 검출
|
WO2023152369A1
(en)
|
2022-02-14 |
2023-08-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Nucleic acid mir-9 inhibitor for the treatment of cystic fibrosis
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|